Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.43 |
| ▸ | FEN1 | P39748 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MYC | P01106 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2451836 | 0.82 | TSHR (0.50) | TSHRACHESMN1; SMN2HPGDERCC5 | |
| SCHEMBL1548711 | 0.81 | NPC1 (0.43) | TSHRACHESMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL5900574 | 0.80 | TSHR (0.47) | TSHRACHESMN1; SMN2HPGDERCC5 | |
| SCHEMBL15970521 | 0.79 | MAOA (0.41) | TSHRACHESMN1; SMN2HPGDERCC5 | |
| SCHEMBL2038760 | 0.79 | ACHE (0.53) | TSHRACHESMN1; SMN2HPGDERCC5 | |
| SCHEMBL6051363 | 0.78 | TSHR (0.45) | TSHRACHESMN1; SMN2HPGDERCC5 | |
| SCHEMBL112406 | 0.78 | HPGD (0.57) | SMN1; SMN2HPGDERCC5FEN1HTT | |
| SCHEMBL11850717 | 0.78 | MAOA (0.48) | TSHRACHESMN1; SMN2HPGDERCC5 | |
| SCHEMBL12438973 | 0.78 | TSHR (0.45) | TSHRACHESMN1; SMN2HPGDERCC5 | |
| SCHEMBL318284 | 0.78 | MAOA (0.48) | TSHRACHESMN1; SMN2HPGDERCC5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1637 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199955-A1 | CORROSION INHIBITOR HAVING SILICA NANOPARTICLES | CHAMPIONX LLC | 2024-06-20 | — | — | US | claimed |
| WO-2024124129-A1 | CORROSION INHIBITOR HAVING SILICA NANOPARTICLES | CHAMPIONX LLC (US) | 2024-06-13 | — | — | WO | claimed |
| US-20240026432-A1 | POLYVINYL SULFONATE DETECTION AND REMOVAL FROM BIOMOLECULE COMPOSITIONS | AMGEN INC. | 2024-01-25 | — | — | US | claimed |
| EP-3548581-B1 | COMPOSITION FOR REMEDIATING IRON SULFIDE IN OILFIELD PRODUCTION SYSTEMS | CHAMPIONX USA INC (US) | 2023-09-06 | — | — | EP | claimed |
| EP-4229219-A2 | POLYVINYL SULFONATE DETECTION AND REMOVAL FROM BIOMOLECULE COMPOSITIONS | Amgen Inc. (US) | 2023-08-23 | — | — | EP | claimed |
| CN-116368239-A | Detection and removal of polyvinylsulfonates from biomolecular compositions | 美国安进公司 | 2023-06-30 | — | — | CN | claimed |
| US-11597868-B2 | Composition for remediating iron sulfide in oilfield production systems | CHAMPIONX USA INC. (US) | 2023-03-07 | — | — | US | claimed |
| WO-2022081939-A2 | POLYVINYL SULFONATE DETECTION AND REMOVAL FROM BIOMOLECULE COMPOSITIONS | AMGEN INC. (US) | 2022-04-21 | — | — | WO | claimed |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | SKC CO., LTD. (KR) | 2022-02-15 | — | — | US | claimed |
| EP-3548581-A1 | COMPOSITION FOR REMEDIATING IRON SULFIDE IN OILFIELD PRODUCTION SYSTEMS | Ecolab USA, Inc. (US) | 2019-10-09 | — | — | EP | claimed |
| EP-0279437-B1 | PROCESS FOR THE PREPARATION OF A BLUE ANTHRAQUINOIC DISPERSE DYE | BASF Aktiengesellschaft (DE) | 1991-10-16 | — | — | EP | claimed |
| EP-0422843-A2 | 6-0 Methylerythromycin A oxime derivatives | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1991-04-17 | — | — | EP | claimed |
| US-4976889-A | 4-formylaminopiperidine derivatives, their use as stabilizers and organic material stabilized with the said derivatives | BASF AKTIENGESELLSCHAFT (DE) | 1990-12-11 | — | — | US | claimed |
| US-4931509-A | EPOXY-CONTAINING MONOMER; EXCELLENT VULCANIZING WITH UREAS, QUATERNARY AMMONIUM AND PHOSPHONIUM SALTS AND POLYCARBOXYLIC ACIDS OR ANHYDRIDES | NIPPON ZEON CO., LTD. (JP) | 1990-06-05 | — | — | US | claimed |
| US-4904796-A | Preparation of a blue anthraquinonoid disperse dye of 1,4-naphthoquinone-[2,]-phthalimides | BASF AKTIENGESELLSCHAFT (DE) | 1990-02-27 | — | — | US | claimed |
| US-4792644-A | ZEOLITE AND QUATERNARY AMMONIUM SALT | TOSOH CORPORATION (JP) | 1988-12-20 | — | — | US | claimed |
| EP-0279437-A2 | Process for the preparation of a blue anthraquinoic disperse dye | BASF Aktiengesellschaft (DE) | 1988-08-24 | — | — | EP | claimed |
| EP-0073566-A1 | Methods and compositions for combating soil pests | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-03-09 | — | — | EP | claimed |
| US-4299989-A | Preparation of ketones | UOP INC. (US) | 1981-11-10 | — | — | US | claimed |
| US-4162278-A | Flame retardant polyphenylene ether resin compositions containing a pentaerythrityl phosphonate | AMERICAN CYANAMID COMPANY (US) | 1979-07-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | PMM2, PGM2, IPMK | TSHR 4018/4885ACHE 1275/4885SMN1; SMN2 3248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.